Corrigendum: Music Therapy in the Psychosocial Treatment of Adult Cancer Patients: A Systematic Review and Meta-Analysis

Köhler, Friederike; Martin, Zoe-Sofia; Hertrampf, Ruth-Susanne; Gäbel, Christine; Keßler, Jens; Ditzen, Beate; Warth, Marco

doi:10.3389/fpsyg.2020.02095

Cited by 4 publications

(1 citation statement)

References 2 publications

(4 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…20 Intervention delivery characteristics include the volume of services provided, the clinical settings (eg, inpatient, outpatient, and virtual) in which they are provided, the demographic and clinical characteristics of patients receiving services, referral characteristics (eg, referring provider type and reason for referral), and the characteristics (eg, length, goals, and interventions) of the sessions provided. Therefore, even with systematic reviews 13,21,22 and numerous RCTs 14,16,18,[23][24][25][26] supporting the efficacy of MT in hematology and oncology, evaluations of its real-world clinical effectiveness within cancer centers are now warranted.…”

Section: Introductionmentioning

confidence: 99%

Clinical Delivery and Effectiveness of Music Therapy in Hematology and Oncology: An EMMPIRE Retrospective Study

et al. 2022

View full text Add to dashboard Cite

Background: Music therapy (MT) has been shown to improve outcomes for patients with sickle cell disease (SCD) and patients with hematologic and/or oncologic conditions excluding SCD (HemOnc) in prior randomized trials. While few studies have described the clinical delivery (ie, volume, clinical settings, patient characteristics, referrals, and session characteristics) of MT and examined its real-world effectiveness, no studies have compared responses between hematology/oncology populations. The purpose of this study was to examine the clinical delivery and effectiveness of MT at a freestanding academic cancer center and compare the effectiveness of MT on pain, anxiety, and fatigue between adult patients in the HemOnc and SCD groups. Methods: A retrospective review was conducted of all MT sessions provided at a freestanding academic cancer center between January 2017 and July 2020. The unadjusted single-session effects of MT on pain, anxiety, and fatigue were assessed among patients reporting symptoms ≥1 out of 10 on a 0 to 10 scale. Adjustments were made for multiple sessions on the same patient using a mixed model to compare pre-session and change scores between the HemOnc and SCD groups. Patients’ comments were analyzed using conventional qualitative content analysis. Results: Music therapists provided 4002 sessions to 1152 patients including 1012 in the HemOnc group and 140 in the SCD group. In the combined sample, statistically significant reductions in pain (1.48 units), anxiety (2.58 units), and fatigue (0.84 units) were observed, with changes in pain and anxiety exceeding clinically significant thresholds. After adjustment, the SCD group reported significantly greater pre-session pain (7.22 vs 5.81) and anxiety (6.11 vs 5.17) as well as greater anxiety reduction (2.89 vs 2.23) than the HemOnc group. Patients’ comments contained themes including enjoyment, gratitude, and improvements in mood, pain, and anxiety. Conclusions: This study supports the delivery and clinical effectiveness of MT for addressing the needs of patients throughout their course of treatment at an academic cancer center and justifies the inclusion of individuals with SCD within integrative oncology services.

show abstract

Section: Introductionmentioning

confidence: 99%

Clinical Delivery and Effectiveness of Music Therapy in Hematology and Oncology: An EMMPIRE Retrospective Study

et al. 2022

View full text Add to dashboard Cite

show abstract

Automatic Music Generation Using Machine Learning

Cosma,

Domuta,

Gota

et al. 2023

2023 International Conference on Electrical, Computer and Energy Technologies (ICECET)

View full text Add to dashboard Cite

Music therapy, quality of life and efficacy of immunotherapy for NSCLC

Duan,

Jia,

Chai

et al. 2023

BMJ Support Palliat Care

View full text Add to dashboard Cite

ObjectiveOur study examines how non-small cell lung cancer (NSCLC) survivors undergoing immunotherapy can experience reduced anxiety and psychological distress, improved quality of life (QOL) and increased immunotherapy efficacy.Methods133 men and 20 women with NSCLCs were enrolled. In a randomised controlled trial involving a care as usual group (CG) and a music therapy group (MTG), the researchers employed various tools such as the Self-Rating Anxiety Scale, Symptom Distress Thermometer, Functional Assessment of Cancer Therapy-General version 4 and Response Evaluation Criteria in Solid Tumours. These measures were used to evaluate anxiety, psychological distress, QOL and immunotherapy efficacy in patients undergoing immunotherapy before and after patients’ completion.ResultsAfter the intervention, patients in the MTG demonstrated a noteworthy reduction in anxiety (t=6.272, p≤0.001) and distress (t=10.111, p≤0.001), as well as an increase in QOL (t=−7.649, p≤0.001). Moreover, compared with patients in the CG, those in the MTG demonstrated a remarkable drop in anxiety (t=−4.72, p≤0.001) and distress (t=−7.29, p≤0.001), a significant increase in QOL (t=5.363, p≤0.001) and a significant improvement in immunotherapy efficacy (z=−2.18, p≤0.05) after the intervention.ConclusionsThe use of individual music therapy sessions appears to be effective in reducing anxiety and distress, while also increasing QOL and immunotherapy efficacy in patients with NSCLCs undergoing immunotherapy.

show abstract

Corrigendum: Music Therapy in the Psychosocial Treatment of Adult Cancer Patients: A Systematic Review and Meta-Analysis

Cited by 4 publications

References 2 publications

Clinical Delivery and Effectiveness of Music Therapy in Hematology and Oncology: An EMMPIRE Retrospective Study

Clinical Delivery and Effectiveness of Music Therapy in Hematology and Oncology: An EMMPIRE Retrospective Study

Automatic Music Generation Using Machine Learning

Music therapy, quality of life and efficacy of immunotherapy for NSCLC

Contact Info

Product

Resources

About